Femtosecond advances help ODs, patientsOur patients have numerous choices regarding advanced technology and eye care. Advances range from how patients check in for an appointment to what tools a surgeon uses to dissect tissue. They all have their benefits, and all come at a cost.
12-month results with small-aperture IOL providing patients with an extended range of visionThe IC-8 IOL (AcuFocus) is one of the new class of extended-depth-of-focus (EDOF) IOLs that is definitively altering the landscape of cataract surgery in Europe and around the world. Whereas monofocal and multifocal lenses have one or two distinct focal points, an EDOF-IOL creates one elongated focal point, though each lens does so in a different way.
Minimally invasive surgical solutions for presbyopia
Minimally invasive surgical solutions for presbyopiaPresbyopia, an age-related loss of accommodative amplitude of the eye resulting in near and intermediate vision deficits, begins to affect most people once they reach their early 40s.
Intracorneal inlays for the correction of presbyopia and low hyperopiaNew alloplastic materials are being used as intracorneal inlays to offer predictable and safe refractive surgical correction of presbyopia and low hyperopia. The major problem with such inlays is the wound-healing response following their insertion; however, they can easily be removed.
New correction option for presbyopes
New correction option for presbyopesAt present we are limited with our ability to treat presbyopes. Sure, we have progressives and multifocal contact lenses; however, from a surgical standpoint, monovision corneal refractive surgery is limited, and clear lens extraction is often extreme for emmetropes.
FDA approves AcuFocus corneal inlayThe FDA has approved AcuFocus’ corneal inlay product (KAMRA inlay.) The device is indicated to improve near vision by extending depth of focus in patients with presbyopia who have emmetropic refractions (+0.50 to –0.75 D).
Quantel, AcuFocus receive CE approvalsOphthalmology technology from Quantel Medical and AcuFocus recently received CE Mark approval.
Two-stage, well-tolerated procedure for inlay ensures refractive stabilityThe optimal time of implantation of a corneal inlay (Kamra, AcuFocus) to correct presbyopia in ametropic presbyopic patients seems to be 1 week after traditional LASIK in a planned two-stage KAMRA procedure.
Replacement of dysfunctional lens may pose multiple benefitsDysfunctional lens replacement may be a better option in certain cases for patients with dysfunctional lens syndrome who initially seek LASIK correction. With the availability of advanced diagnostic equipment, surgeons can now identify candidates and recommend this solution.
FDA: Kamra inlay benefits outweigh risksFollowing deliberations, the FDA’s ophthalmic devices advisory panel has determined that the benefits of AcuFocus’ Kamra inlay outweigh the risks for patients suffering vision loss as a result of presbyopia.